DEFINING THE CANCER MASTER SWITCH
Defining the Cancer Master Switch.
Archive for Publications
RANDOMIZED PLACEBO-CONTROLLED PHASE II TRIAL OF PERIFOSINE PLUS CAPECITABINE AS SECOND- OR THIRD-LINE THERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER
Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine as Second- or Third-Line Therapy in Patients with Metastatic Colorectal Cancer.
PDX-1: DEMONSTRATION OF ONCOGENIC PROPERTIES IN PANCREATIC CANCER
PDX-1: Demonstration of Oncogenic Properties in Pancreatic Cancer.
CLINICAL DEVELOPMENT DIRECTIONS IN ONCOLYTIC VIRAL THERAPY
Clinical Development Directions in Oncolytic Viral Therapy.
PHASE I TRIAL OF TGF-SS2 ANTISENSE-GMCSF GENE MODIFIED AUTOLOGOUS TUMOR CELL (TAG) VACCINE
Phase I Trial of TGF-ß2 Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine.
PROCOAGULANT INHIBITORY PROPERTIES OF PACLITAXEL POLYGLUMEX
Procoagulant Inhibitory Properties of Paclitaxel Polyglumex. International Journal of General Medicine 2011; (4):5-11.
PERSONALIZED CANCER APPROACH: USING RNA INTERFERENCE TECHNOLOGY
Personalized Cancer Approach: Using RNA Interference Technology. World Journal of Surgery 2011 Aug; 35(8):1700-1714.
IN VIVO SAFETY AND ANTITUMOR EFFICACY OF BIFUNCTIONAL SMALL HAIRPIN RNAS SPECIFIC FOR THE HUMAN STATHMIN 1 ONCOPROTEIN
In vivo Safety and Antitumor Efficacy of Bifunctional Small Hairpin RNAs Specific for the Human Stathmin 1 Oncoprotein.
APPLICATIONS OF HPLC-MALDI-TOF MS/MS PHOSPHOPROTEOMIC ANALYSIS IN ONCOLOGICAL CLINICAL DIAGNOSTICS
Applications of HPLC-MALDI-TOF MS/MS Phosphoproteomic Analysis in Oncological Clinical Diagnostics. Current Proteomics 2011
MULTIFUNCTIONAL VACCINES IN CANCER: THE ‘TRIAD’ APPROACH
Nemunaitis J: Multifunctional Vaccines in Cancer: The ‘Triad’ Approach.